Your search returned 362 results.

Results
	261.	Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. [electronic resource] by Nakagawa, Kazuhiko Garon, Edward B Seto, Takashi Nishio, Makoto Ponce Aix, Santiago Paz-Ares, Luis Chiu, Chao-Hua Park, Keunchil Novello, Silvia Nadal, Ernest Imamura, Fumio Yoh, Kiyotaka Shih, Jin-Yuan Au, Kwok Hung Moro-Sibilot, Denis Enatsu, Sotaro Zimmermann, Annamaria Frimodt-Moller, Bente Visseren-Grul, Carla Reck, Martin Producer: 20200629 In: The Lancet. Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	262.	Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial. [electronic resource] by Petrylak, Daniel P de Wit, Ronald Chi, Kim N Drakaki, Alexandra Sternberg, Cora N Nishiyama, Hiroyuki Castellano, Daniel Hussain, Syed A Fléchon, Aude Bamias, Aristotelis Yu, Evan Y van der Heijden, Michiel S Matsubara, Nobuaki Alekseev, Boris Necchi, Andrea Géczi, Lajos Ou, Yen-Chuan Coskun, Hasan Senol Su, Wen-Pin Bedke, Jens Gakis, Georgios Percent, Ivor J Lee, Jae-Lyun Tucci, Marcello Semenov, Andrey Laestadius, Fredrik Peer, Avivit Tortora, Giampaolo Safina, Sufia Garcia Del Muro, Xavier Rodriguez-Vida, Alejo Cicin, Irfan Harputluoglu, Hakan Tagawa, Scott T Vaishampayan, Ulka Aragon-Ching, Jeanny B Hamid, Oday Liepa, Astra M Wijayawardana, Sameera Russo, Francesca Walgren, Richard A Zimmermann, Annamaria H Hozak, Rebecca R Bell-McGuinn, Katherine M Powles, Thomas Producer: 20200625 In: The Lancet. Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	263.	Effective Treatment of Cytotoxic Agent Refractory Alpha-Fetoprotein-Producing Gastric Cancer with Ramucirumab: a Case Report and Review of the Literature. [electronic resource] by Takada, Jun Araki, Hiroshi Ozawa, Noritaka Sugiyama, Tomohiko Kubota, Masaya Ibuka, Takashi Shimizu, Masahito Producer: 20200217 In: Journal of gastrointestinal cancer vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	264.	Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma. [electronic resource] by Jones, Robin L Katz, Daniela Loggers, Elizabeth T Davidson, Darin Rodler, Eve T Pollack, Seth M Producer: 20180618 In: Medical oncology (Northwood, London, England) vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	265.	Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 [electronic resource] by Tada, Yasuko Togashi, Yosuke Kotani, Daisuke Kuwata, Takeshi Sato, Eichi Kawazoe, Akihito Doi, Toshihiko Wada, Hisashi Nishikawa, Hiroyoshi Shitara, Kohei Producer: 20191016 In: Journal for immunotherapy of cancer vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	266.	Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. [electronic resource] by Lu, Jian Zhang, Xiu-Ping Zhong, Bin-Yan Lau, Wan Yee Madoff, David C Davidson, Jon C Qi, Xiaolong Cheng, Shu-Qun Teng, Gao-Jun Producer: 20200525 In: The lancet. Gastroenterology & hepatology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	267.	TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast cancer. [electronic resource] by Mackey, John Gelmon, Karen Martin, Miguel McCarthy, Nicole Pinter, Tamas Rupin, Mathieu Youssoufian, Hagop Producer: 20100216 In: Clinical breast cancer vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	268.	Receptor kinase inhibitors target NSCLC: two antibodies and a small-molecule MET inhibitor. [electronic resource] by Yee, David Producer: 20111207 In: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	269.	Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy. [electronic resource] by Moore, M Gill, S Asmis, T Berry, S Burkes, R Zbuk, K Alcindor, T Jeyakumar, A Chan, T Rao, S Spratlin, J Tang, P A Rothenstein, J Chan, E Bendell, J Kudrik, F Kauh, J Tang, S Gao, L Kambhampati, S R P Nasroulah, F Yang, L Ramdas, N Binder, P Strevel, E Producer: 20171226 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	270.	Current Perspectives on Gastric Cancer. [electronic resource] by Marqués-Lespier, Juan M González-Pons, María Cruz-Correa, Marcia Producer: 20170614 In: Gastroenterology clinics of North America vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	271.	Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. [electronic resource] by Janmaat, Vincent T Steyerberg, Ewout W van der Gaast, Ate Mathijssen, Ron Hj Bruno, Marco J Peppelenbosch, Maikel P Kuipers, Ernst J Spaander, Manon Cw Producer: 20180116 In: The Cochrane database of systematic reviews vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	272.	East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL). [electronic resource] by Park, Keunchil Kim, Joo-Hang Cho, Eun Kyung Kang, Jin-Hyoung Shih, Jin-Yuan Zimmermann, Annamaria Hayden Lee, Pablo Alexandris, Ekaterine Puri, Tarun Orlando, Mauro Producer: 20180202 In: Cancer research and treatment vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	273.	Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. [electronic resource] by Pérol, Maurice Ciuleanu, Tudor-Eliade Arrieta, Oscar Prabhash, Kumar Syrigos, Konstantinos N Goksel, Tuncay Park, Keunchil Kowalyszyn, Ruben Dario Pikiel, Joanna Lewanski, Conrad R Thomas, Michael Dakhil, Shaker Kim, Joo-Hang Karaseva, Nina Yurasov, Sergey Zimmermann, Annamaria Lee, Pablo Carter, Gebra Cuyun Reck, Martin Cappuzzo, Federico Garon, Edward B Producer: 20161104 In: Lung cancer (Amsterdam, Netherlands) vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	274.	The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. [electronic resource] by Roviello, Giandomenico Petrioli, Roberto Rosellini, Pietro Multari, Andrea Giovanni Conca, Raffaele Paganini, Giovanni Chiriacò, Giorgio Aieta, Michele Producer: 20200220 In: Investigational new drugs vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	275.	Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study. [electronic resource] by Takemoto, Shinnosuke Fukuda, Minoru Yamaguchi, Hiroyuki Ikeda, Takaya Akagi, Kazumasa Tomono, Hiromi Umeyama, Yasuhiro Dotsu, Yosuke Taniguchi, Hirokazu Gyotoku, Hiroshi Senju, Hiroaki Kitazaki, Takeshi Nakatomi, Katsumi Nagashima, Seiji Fukuda, Masaaki Kinoshita, Akitoshi Soda, Hiroshi Mukae, Hiroshi Producer: 20210305 In: Thoracic cancer vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	276.	Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era. [electronic resource] by Shah, Manish A Producer: 20140828 In: Nature reviews. Clinical oncology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	277.	Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma. [electronic resource] by Rogers, Jane E Xiao, Lianchun Amlashi, Fatemeh G Elimova, Elena Blum Murphy, Mariela A Sanders, Elizabeth Shanbhag, Namita Thomas, Irene Ajani, Jaffer A Producer: 20190513 In: Oncology vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	278.	Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC. [electronic resource] by Niu, Meng Hong, Duo Ma, Teng-Chuang Chen, Xiao-Wei Han, Jin-Hang Sun, Jun Xu, Ke Producer: 20170215 In: Medicine vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	279.	Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study. [electronic resource] by Parisi, Alessandro Cortellini, Alessio Roberto, Michela Venditti, Olga Santini, Daniele Dell'Aquila, Emanuela Stellato, Marco Marchetti, Paolo Occhipinti, Mario Alberto Zoratto, Federica Mazzuca, Federica Tinari, Nicola De Tursi, Michele Iezzi, Laura Natoli, Clara Ratti, Margherita Pizzo, Claudio Ghidini, Michele Porzio, Giampiero Ficorella, Corrado Cannita, Katia Producer: 20190828 In: Journal of cancer research and clinical oncology vol. 145 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	280.	Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression. [electronic resource] by Obermannová, R Van Cutsem, E Yoshino, T Bodoky, G Prausová, J Garcia-Carbonero, R Ciuleanu, T Garcia Alfonso, P Portnoy, D Cohn, A Yamazaki, K Clingan, P Lonardi, S Kim, T W Yang, L Nasroulah, F Tabernero, J Producer: 20171226 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 362 results.